Copyright: ©Author(s) 2026.
World J Clin Oncol. Nov 24, 2026; 17(11): 125917
Published online Nov 24, 2026. doi: 10.5306/wjco.125917
Published online Nov 24, 2026. doi: 10.5306/wjco.125917
Figure 1 Spatial transcriptomics reveals distinct regions enriched for M1-like and M2-like signatures and their clinical relevance in colorectal cancer.
A: Spatial feature plots showing AUCell-based M1-like and M2-like macrophage-associated transcriptional-program scores across a conventional 10x Genomics Visium FFPE colorectal cancer (CRC) specimen from tissue block 1281585B, slide V10L13-021, capture area B1. Each point represents one spatial spot rather than an individual cell; B: Comparison of mean AUCell signature scores for the M1-like and M2-like macrophage-associated transcriptional programs across malignant, mixed, and normal regions of specimen CRC2; P values for regional comparisons are shown. AUCell scores represent gene-set activity and are distinct from receiver-operating-characteristic area under the curve (AUC); C: Correlation-based spatial association matrix and network visualization illustrating the association between macrophage signature activity (AUC) and inferred abundances of major tumor microenvironment cell types (e.g., CD4⁺ T cells, CD8⁺ T cells, NK cells, B cells, plasma cells, macrophages, DCs, neutrophils, endothelial cells, fibroblasts, epithelial cells, and tumor cells). The colors indicate positive/negative correlations, and the line thickness reflects the correlation strength; D: Violin/box plots of single-sample gene set enrichment analysis (ssGSEA) scores for M1 and M2 signatures in early-stage (I–II) vs advanced-stage (III-IV) CRC; E: Kaplan–Meier analysis of overall survival stratified by high vs low M1 or M2 ssGSEA scores; group sizes and log-rank P values are indicated. CRC: Colorectal cancer; ssGSEA: Single-sample gene set enrichment analysis; TME: Tumor microenvironment.
- Citation: Lin X, Lin ZL, Li Y, Huang CD, Chen S, Shi DL, Chen XQ. Spatial macrophage signatures and prognostic relevance of NFKB1 in colorectal cancer. World J Clin Oncol 2026; 17(11): 125917
- URL: https://www.wjgnet.com/2218-4333/full/v17/i11/125917.htm
- DOI: https://dx.doi.org/10.5306/wjco.125917